Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

Clinical trial NCT03833141 · COMPLETED

Trial details

NCT number: NCT03833141
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Severe Eosinophilic Asthma

Start date: 2018-11-12
Primary completion: 2024-05-28
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.